Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NICE proposes to withdraw Alzheimer's drugs from NHS.

× No keyword cloud information.

8 in total

1. Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease.

Authors: Stefan J Teipel; Michael Ewers; Veronika Reisig; Bernd Schweikert; Harald Hampel; Michael Happich
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2007-04-01 Impact factor: 5.270

Review 2. The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors: Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal: Chem Rev Date: 2013-02-25 Impact factor: 60.622

3. Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping.

Authors: Mark D Lindner; John B Hogan; Donald B Hodges; Anitra F Orie; Ping Chen; Jason A Corsa; John E Leet; Kevin W Gillman; Gregory M Rose; Kelli M Jones; Valentin K Gribkoff
Journal: Psychopharmacology (Berl) Date: 2006-09-27 Impact factor: 4.530

Review 4. NMDA receptors in clinical neurology: excitatory times ahead.

Authors: Lorraine V Kalia; Suneil K Kalia; Michael W Salter
Journal: Lancet Neurol Date: 2008-08 Impact factor: 44.182

Review 5. Cholinesterase inhibitors: drugs looking for a disease?

Authors: Marina Maggini; Nicola Vanacore; Roberto Raschetti
Journal: PLoS Med Date: 2006-04-11 Impact factor: 11.069

Review 6. Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients.

Authors: Lídia Blanco-Silvente; Xavier Castells; Marc Saez; Maria Antònia Barceló; Josep Garre-Olmo; Joan Vilalta-Franch; Dolors Capellà
Journal: Int J Neuropsychopharmacol Date: 2017-07-01 Impact factor: 5.176

Review 7. Treatment of Alzheimer's disease across the spectrum of severity.

Authors: Shailaja Shah; William E Reichman
Journal: Clin Interv Aging Date: 2006 Impact factor: 4.458

8. Medication adherence and tolerability of Alzheimer's disease medications: study protocol for a randomized controlled trial.

Authors: Noll L Campbell; Paul Dexter; Anthony J Perkins; Sujuan Gao; Lang Li; Todd C Skaar; Amie Frame; Hugh C Hendrie; Chris M Callahan; Malaz A Boustani
Journal: Trials Date: 2013-05-04 Impact factor: 2.279

8 in total